Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.03B | 3.27B | 3.54B | 3.67B | 3.55B | Gross Profit |
1.13B | 1.02B | 1.08B | 1.12B | 1.15B | EBIT |
102.50M | -385.63M | -15.24M | -54.38M | -20.92M | EBITDA |
235.85M | -135.92M | 148.57M | 108.47M | 83.01M | Net Income Common Stockholders |
-203.60M | -385.63M | 36.94M | 3.51M | -191.66M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
486.10M | 623.22M | 681.15M | 746.92M | 940.42M | Total Assets |
3.40B | 4.27B | 4.74B | 4.96B | 5.22B | Total Debt |
2.05B | 2.48B | 2.52B | 2.56B | 2.78B | Net Debt |
1.58B | 1.88B | 1.85B | 1.82B | 1.86B | Total Liabilities |
3.98B | 4.64B | 4.68B | 4.84B | 5.15B | Stockholders Equity |
-578.43M | -368.58M | 60.65M | 112.63M | 66.39M |
Cash Flow | Free Cash Flow | |||
156.77M | -23.41M | 51.14M | 117.47M | 196.99M | Operating Cash Flow |
229.17M | 79.47M | 175.98M | 301.51M | 301.97M | Investing Cash Flow |
-49.06M | -122.83M | -24.27M | -155.25M | -75.69M | Financing Cash Flow |
-305.45M | -31.27M | -198.08M | -330.37M | -235.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $52.98B | 13.88 | 14.74% | 2.50% | 0.34% | -8.45% | |
71 Outperform | $15.94B | 19.33 | 37.70% | 1.29% | 24.07% | 27.40% | |
71 Outperform | $82.61B | 14.23 | 35.96% | 6.81% | 1.30% | -0.76% | |
68 Neutral | $4.99B | 28.34 | 18.34% | 0.99% | -4.72% | -22.46% | |
65 Neutral | $14.39B | 26.33 | 13.97% | 1.24% | -3.82% | -12.80% | |
64 Neutral | $4.46B | 11.94 | 5.17% | 249.36% | 4.00% | -12.35% | |
49 Neutral | $1.67B | 35.82 | 35.20% | 2.28% | -29.43% | ― |
On May 13, 2025, Pitney Bowes Inc. held its Annual Meeting where stockholders approved several proposals, including the election of directors and the ratification of PricewaterhouseCoopers LLP as the independent registered public accountants for 2025. Additionally, the Amended Pitney Bowes Inc. 2024 Stock Plan was approved, and an advisory vote on executive compensation was passed, indicating continued support for the company’s strategic direction and governance.
The most recent analyst rating on (PBI) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Pitney Bowes stock, see the PBI Stock Forecast page.